Challenges of Local Recurrence and Cure in Low Grade Malignant Tumors of the Spine
- 1 October 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Spine
- Vol. 34 (Supplement), S48-S57
- https://doi.org/10.1097/brs.0b013e3181b969ac
Abstract
Systematic review and ambispective multicenter cohort study.1. To compare the effects of wide/marginal (en bloc) resection with intralesional resection on local recurrence and survival for chordomas and chondrosarcomas of the spine. 2. To determine the influence of radiation therapy in the management of chordomas and chondrosarcomas.Chordomas and chondrosarcomas of the spine are prone to local recurrence and death despite being low-grade malignant tumors. No study to date has enough numbers or adequate scientific rigor to determine the influence of resection or radiation therapy on outcome.A systematic review was performed to evaluate the 2 objectives. In addition an ambispective multicenter cohort analysis of chordomas and chondrosarcomas was performed. The GRADE system of analysis integrating the results of the systematic review, the multicenter cohort study and the expert opinion of the Spine Oncology Study Group (SOSG) was used to arrive at treatment recommendations.A total of 63 articles were included in the systematic reviews. Evidence was low quality. En bloc resection appeared to improve both local recurrence and disease free survival in Chordoma and Chondrosarcoma. Radiation therapy had a positive impact on the management of Chordoma and Chondrosarcoma with predictably low side effects. The cohort analysis showed significantly decreased local recurrence for Chordoma (P < 0.0001) and Chondrosarcoma (P < 0.0001) with en bloc resection, and significantly decreased death for both Chordoma (P = 0.0001) and Chondrosarcoma (P = 0.0015) with en bloc resection.When wide or marginal margins (en bloc) are achieved in surgical resection of chordomas and chondrosarcomas of the spine there is a decrease in local recurrence and mortality. Therefore, en bloc resection should be undertaken for the treatment of chordomas and chondrosarcomas of the spine. Strong Recommendation, Moderate Quality Evidence.Radiation therapy of at least 60 to 65 Gy equivalents is indicated as an adjuvant treatment for chordoma and chondrosarcoma of the spine when there has been incomplete resection or an intralesional margin. Weak Recommendation, Low Quality Evidence.Keywords
This publication has 74 references indexed in Scilit:
- Sacral Chordoma: Can Local Recurrence After Sacrectomy Be Predicted?Published by Ovid Technologies (Wolters Kluwer Health) ,2008
- Chondroma/Chondrosarcoma of the SpineNeurosurgery Clinics of North America, 2008
- Chordoma of the Spinal ColumnNeurosurgery Clinics of North America, 2008
- Chordomas of the craniospinal axis: multimodality surgical, radiation and medical management strategiesExpert Review of Neurotherapeutics, 2007
- Effectiveness of Cetuximab/Gefitinib in the Therapy of a Sacral ChordomaOncology Research and Treatment, 2006
- Oncologic and Functional Outcome Following Sacrectomy for Sacral ChordomaThe Journal of Bone & Joint Surgery, 2006
- Operative Management of Sacral ChordomaThe Journal of Bone and Joint Surgery (American), 2005
- Imatinib mesylate in chordomaCancer, 2004
- Current management of sacral chordomaNeurosurgical Focus, 2003
- A System of Staging Musculoskeletal NeoplasmsPublished by Ovid Technologies (Wolters Kluwer Health) ,1986